Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for American Healthcare REIT (AHR) over the last 10 years, with Q3 2025 value amounting to $184.4 million.

  • American Healthcare REIT's Cash & Equivalents rose 5801.82% to $184.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $184.4 million, marking a year-over-year increase of 5801.82%. This contributed to the annual value of $123.3 million for FY2024, which is 3582.1% up from last year.
  • Per American Healthcare REIT's latest filing, its Cash & Equivalents stood at $184.4 million for Q3 2025, which was up 5801.82% from $133.5 million recorded in Q2 2025.
  • In the past 5 years, American Healthcare REIT's Cash & Equivalents registered a high of $184.4 million during Q3 2025, and its lowest value of $35.2 million during Q3 2023.
  • Its 5-year average for Cash & Equivalents is $85.5 million, with a median of $79.4 million in 2022.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 38325.25% in 2021, then plummeted by 5570.69% in 2023.
  • Over the past 5 years, American Healthcare REIT's Cash & Equivalents (Quarter) stood at $81.6 million in 2021, then fell by 20.28% to $65.1 million in 2022, then surged by 39.55% to $90.8 million in 2023, then soared by 35.82% to $123.3 million in 2024, then surged by 49.52% to $184.4 million in 2025.
  • Its last three reported values are $184.4 million in Q3 2025, $133.5 million for Q2 2025, and $86.1 million during Q1 2025.